Biosig Technologies (BSGM) Competitors $7.66 -0.85 (-9.99%) Closing price 06/27/2025 04:00 PM EasternExtended Trading$7.82 +0.16 (+2.09%) As of 06/27/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock BSGM vs. SIBN, CBLL, EMBC, AVNS, RXST, BVS, BFLY, KIDS, DCTH, and AXGNShould you be buying Biosig Technologies stock or one of its competitors? The main competitors of Biosig Technologies include SiBone (SIBN), CeriBell (CBLL), Embecta (EMBC), AVANOS MEDICAL (AVNS), RxSight (RXST), Bioventus (BVS), Butterfly Network (BFLY), OrthoPediatrics (KIDS), Delcath Systems (DCTH), and AxoGen (AXGN). These companies are all part of the "medical equipment" industry. Biosig Technologies vs. Its Competitors SiBone CeriBell Embecta AVANOS MEDICAL RxSight Bioventus Butterfly Network OrthoPediatrics Delcath Systems AxoGen SiBone (NASDAQ:SIBN) and Biosig Technologies (NASDAQ:BSGM) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, analyst recommendations, profitability, institutional ownership, dividends, media sentiment and valuation. Which has more risk and volatility, SIBN or BSGM? SiBone has a beta of 0.94, suggesting that its share price is 6% less volatile than the S&P 500. Comparatively, Biosig Technologies has a beta of 1.66, suggesting that its share price is 66% more volatile than the S&P 500. Is SIBN or BSGM more profitable? Biosig Technologies has a net margin of 0.00% compared to SiBone's net margin of -15.03%. SiBone's return on equity of -16.00% beat Biosig Technologies' return on equity.Company Net Margins Return on Equity Return on Assets SiBone-15.03% -16.00% -11.69% Biosig Technologies N/A -5,336.99%-398.16% Do analysts prefer SIBN or BSGM? SiBone presently has a consensus price target of $22.50, suggesting a potential upside of 22.08%. Biosig Technologies has a consensus price target of $10.00, suggesting a potential upside of 30.55%. Given Biosig Technologies' higher probable upside, analysts plainly believe Biosig Technologies is more favorable than SiBone.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SiBone 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00Biosig Technologies 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has preferable earnings and valuation, SIBN or BSGM? Biosig Technologies has lower revenue, but higher earnings than SiBone. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSiBone$167.18M4.70-$30.91M-$0.64-28.80Biosig Technologies$40K5,227.95-$10.33MN/AN/A Do insiders and institutionals hold more shares of SIBN or BSGM? 98.1% of SiBone shares are owned by institutional investors. Comparatively, 7.2% of Biosig Technologies shares are owned by institutional investors. 4.0% of SiBone shares are owned by company insiders. Comparatively, 17.0% of Biosig Technologies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Does the media favor SIBN or BSGM? In the previous week, Biosig Technologies had 3 more articles in the media than SiBone. MarketBeat recorded 4 mentions for Biosig Technologies and 1 mentions for SiBone. SiBone's average media sentiment score of 1.87 beat Biosig Technologies' score of 0.92 indicating that SiBone is being referred to more favorably in the media. Company Overall Sentiment SiBone Very Positive Biosig Technologies Positive SummaryBiosig Technologies beats SiBone on 7 of the 13 factors compared between the two stocks. Get Biosig Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for BSGM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BSGM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BSGM vs. The Competition Export to ExcelMetricBiosig TechnologiesMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$209.08M$6.81B$5.47B$8.93BDividend YieldN/A1.04%5.34%4.14%P/E RatioN/A26.5826.1419.65Price / Sales5,227.9580.56387.56105.07Price / CashN/A21.0136.4056.84Price / Book-85.114.737.875.43Net Income-$10.33M$171.62M$3.16B$249.20M7 Day Performance14.33%2.79%3.09%3.99%1 Month Performance30.94%-0.64%6.03%5.31%1 Year Performance2,087.95%18.98%32.07%17.09% Biosig Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BSGMBiosig Technologies2.1636 of 5 stars$7.66-10.0%$10.00+30.5%+1,970.3%$209.08M$40K0.0050Gap DownHigh Trading VolumeSIBNSiBone4.1035 of 5 stars$16.52+0.8%$22.50+36.2%+48.3%$698.45M$167.18M-25.81350CBLLCeriBell2.7444 of 5 stars$18.49+3.2%$32.50+75.8%N/A$647.32M$65.44M0.00N/AAnalyst ForecastEMBCEmbecta4.4137 of 5 stars$9.82+0.5%$19.33+96.9%-22.6%$570.98M$1.12B10.912,100News CoverageAVNSAVANOS MEDICAL1.7723 of 5 stars$12.09-0.4%N/A-37.7%$561.40M$687.80M-1.442,227RXSTRxSight2.9495 of 5 stars$13.54-0.5%$37.90+179.9%-78.6%$553.07M$139.93M-20.21220BVSBioventus3.3429 of 5 stars$6.52-0.5%$14.33+119.8%+18.4%$535.58M$567.70M-10.691,200News CoverageBFLYButterfly Network1.8274 of 5 stars$2.05-1.4%$4.00+95.1%+123.6%$514.36M$82.06M-7.07460Gap DownKIDSOrthoPediatrics4.3297 of 5 stars$20.59+1.5%$35.83+74.0%-25.8%$492.77M$204.73M-11.77200News CoveragePositive NewsAnalyst UpgradeDCTHDelcath Systems3.3629 of 5 stars$13.26-4.3%$24.00+81.0%+64.9%$482.34M$37.21M-26.5260Gap DownAXGNAxoGen2.7323 of 5 stars$9.79+0.6%$22.20+126.8%+45.4%$443.14M$187.34M-65.26450Positive News Related Companies and Tools Related Companies SiBone Competitors CeriBell Competitors Embecta Competitors AVANOS MEDICAL Competitors RxSight Competitors Bioventus Competitors Butterfly Network Competitors OrthoPediatrics Competitors Delcath Systems Competitors AxoGen Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BSGM) was last updated on 6/28/2025 by MarketBeat.com Staff From Our Partners3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biosig Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biosig Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BSGM Stock Free BSGM Stock Alerts